UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 4 | April 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 3
March-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2403028


Registration ID:
533256

Page Number

a208-a223

Share This Article


Jetir RMS

Title

Stability-Indicating Method Development and Validation for Estimation of Eliglustat in Formulation by High Performance Liquid Chromatography.

Abstract

In RP-HPLC method, the conditions were optimized to obtain an adequate separation of eluted compounds. To separate the title components, a variety of mobile phase compositions were initially used. Mobile phase and flow rate selection was based on peak parameters (height, tailing, theoretical plates, capacity or symmetry factor), run time and resolution. The mobile phase containing mixture of Methanol:Acetonitrile(75:25v/v)with a flow rate of 1.0 ml/min is quite robust. The optimum wavelength for detection was 282 nm at which better detector response for both the drugs was obtained. The retention time of Eliglustat was found to be 4.014 min. System appropriateness studies on freshly manufactured stock solutions were done to gauge its efficacy. The calibration was linear in concentration range of 20 to 140 μg/ ml, with regression 0.9997. The low values of % R.S.D indicate the method is precise and accurate. The mean recoveries were found above 100.53 % for the drug. By performing validation in accordance with ICH guidelines, the Method was examined. Eliglustat in its pharmaceutical dosage form is routinely analyzed using the method by RP-HPLC as a result of its validation.

Key Words

Eliglustat, RP-HPLC, Gaucher Disease, Pharmaceutical dosage form, etc.

Cite This Article

"Stability-Indicating Method Development and Validation for Estimation of Eliglustat in Formulation by High Performance Liquid Chromatography.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 3, page no.a208-a223, March-2024, Available :http://www.jetir.org/papers/JETIR2403028.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Stability-Indicating Method Development and Validation for Estimation of Eliglustat in Formulation by High Performance Liquid Chromatography.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 3, page no. ppa208-a223, March-2024, Available at : http://www.jetir.org/papers/JETIR2403028.pdf

Publication Details

Published Paper ID: JETIR2403028
Registration ID: 533256
Published In: Volume 11 | Issue 3 | Year March-2024
DOI (Digital Object Identifier):
Page No: a208-a223
Country: NAGPUR, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000313

Print This Page

Current Call For Paper

Jetir RMS